Loading decisions…
Loading decisions…
2,524 vetted Board decisions in 2025.
The Board denied a disability rating in excess of 30 percent for CAD prior to October 17, 2022, and a rating in excess of 60 percent from October 17, 2022.
The Board granted service connection for a psychiatric disability but denied service connection for heart disability, type 2 diabetes mellitus, left lower peripheral neuropathy, and right lower peripheral neuropathy.
The Board remands the matter to ensure that the Veteran is provided a fully adequate medical opinion regarding the severity of his coronary artery disease (CAD) prior to May 28, 2015.
The Board granted service connection for coronary artery disease and hypertension under the PACT Act, presumptively linking both conditions to herbicide agent exposure in Thailand.
The Veteran's service-connected conditions of CAD, diabetes mellitus, and peripheral neuropathy prevent him from obtaining or maintaining substantially gainful employment.
The Board granted service connection for eczema based on toxic exposure during the Veteran's deployment to Afghanistan, as supported by a positive nexus opinion. The claim for coronary artery disease (CAD) was remanded for further evidence.
The Board remands the claims for service connection for various conditions, including headaches, nervous condition, skin lesions, sleep apnea, and heart condition/atrial fibrillation, to correct pre-decisional duty to assist errors.
The Board granted service connection for sleep apnea, headaches, and a heart condition, finding that these conditions are as likely as not related to the Veteran's active-duty service.
The Board dismissed the legacy appeals for service connection for ischemic heart disease and bilateral hearing loss due to a claims processing defect.
The Board granted service connection for unspecified anxiety disorder and denied service connection for PTSD, diabetes mellitus, type II, sleep apnea, hypertension, heart disability, headaches, erectile dysfunction, and remanded the claims for secondary service connection and TDIU.
The Board denied service connection for a vision disability, to include hyperopia and presbyopia, and remanded several other claims including those for kidney, hypertension, sleep apnea, diabetes mellitus, lower extremity neuropathy, hip, knee, heart, neck, upper extremity radiculopathy, and TDIU.
The Board granted service connection for diabetes mellitus and coronary artery disease (CAD) based on the Veteran's exposure to herbicides, as presumed under the PACT Act.
The Board denied the Veteran's request for an earlier effective date for the grant of service connection for diabetes mellitus type 2, hypertension, and coronary artery bypass graft (CABG), coronary artery disease, and status post myocardial infarction.
The Board denied the appeal for service connection for coronary artery disease for the purposes of retroactive benefits under Nehmer v. Department of Veterans Affairs, as the Veteran is not a Nehmer class member.
The Board remands the issues of service connection for squamous cell carcinoma of the mouth and throat, other accrued benefits, service connection for any disease presumed to be due to exposure to tactical herbicides, and an earlier effective date for coronary artery disease for further development.
The Board remands the claims for service connection for heart conditions, high blood pressure, and generalized anxiety disorder with unspecified depressive disorder due to a need for additional evidence.
The Board granted service connection for multiple conditions, including ischemic heart disease with coronary artery disease, Type II diabetes mellitus, and Parkinson's disease, effective from October 20, 2017.
The Board granted initial ratings of 70 percent for right hand essential tremors, 60 percent for left hand essential tremors, and 30 percent for asbestosis with pulmonary nodule. It denied a rating higher than 30 percent for asbestosis, a compensable rating for bilateral hearing loss, and remanded issues related to atrial fibrillation, coronary artery disease, and increased ratings.
The Board denied the veteran's claim for service connection for ischemic heart disease, as there is no current diagnosis of the condition.
The Board granted an effective date of October 7, 2014, for coronary artery disease and January 6, 2020, for diabetes mellitus Type II. The remaining issues are remanded.
← Back to Ischemic heart disease overview
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.